Company / Revenue per Share
NewAmsterdam Pharma Co N.V. Revenue per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.19
FY2025
5-year range
$0.17 / $5.41
FY2022-FY2025
Trend
-60.6%
vs FY2024
Sector context
#126 of 148
Health Care
What the data says
NewAmsterdam Pharma Co N.V.'s revenue per share of $0.19 is lower than 85% of companies in the Health Care sector (FY2025). Improved from $0.17 to $0.19 over the past 2 years.
Based on SEC 10-K filings.
0.19 in FY2025 with a 3-year CAGR of -67.3%.
Improved from $0.17 to $0.19 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -67.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 148This company $0.19 Sector average $20.24
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 60.6% year-over-year.
- Ranks #126 out of 148 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | -60.6% |
| FY2024 | $0.48 | +181.6% |
| FY2023 | $0.17 | -96.8% |
| FY2022 | $5.41 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026